Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$11.01
-0.51-4.43%
Last update: Oct 6, 4:00 PM
$11.01
-0.51-4.43%
Keros Therapeutics Inc (KROS) Stock Price, Quote, News & History
KROSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Keros Therapeutics (NASDAQ:KROS) through any online brokerage.
Other companies in Keros Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Keros Therapeutics has a consensus price target of $25.54.
The stock price for Keros Therapeutics (NASDAQ: KROS) is $11.01 last updated October 6, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Keros Therapeutics.
Keros Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Keros Therapeutics.
Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
